Bone mineral density measured by dual-energy X-ray absorptiometry in healthy finnish women

Summary A cross-sectional study of 351 healthy Finnish women aged 20–76 years was done to establish reference values of bone mineral density (BMD) using dual-energy X-ray absorptiometry (DEXA). The effects of age and of several physical and lifestyle factors on BMD of the lumbar spine and proximal femur (femoral neck, trochanter, and Ward's triangle area) were investigated. Altogether 58 women were excluded from the final analysis due to significant spinal osteoarthritis or other diseases or drugs known to influence calcium or bone metabolism. The precision of the method was 0.9, 1.2, 2.7, and 2.4% in the lumbar, femoral neck, Ward's triangle and trochanter area, respectively. Lumbar BMD was increased by 30% (P<0.001) in 15 patients with osteoarthritis (21% of women 50 years or older), but it was apparently unaffected in 5 cases with aortic calcification. Except for the trochanter area, BMD diminished along with age, and this was significant after the menopause. The peak of mean BMD was observed at the age of 31–35 years in the spine and at the age of 20–25 years in the femoral neck and Ward's triangle. BMD was in a positive relationship to weight both in premenopausal and postmenopausal women and to the use of oral contraceptives in premenopausal women and to that of estrogen replacement therapy in postmenopausal women. Labors and pregnancies had a weak positive effect on BMD in premenopausal women. As compared with nonusers premenopausal women who had used alcohol showed a slightly decreased BMD of Ward's triangle. In postmenopausal women there was a positive correlation between alcohol intake and BMD.     

Bone mineral density in hemodialysis patients with parathyroid dysfunction

We have determined bone mineral density (BMD) in hemodialysis patients with various parathyroid function in an attempt to elucidate the pathology of bone abnormalities, and obtained the following results. It is desirable that BMD (DXA) in the dialysis patients is determined at the radius rather than at the lumber spine. A higher BMD value might be obtained because of osteosclerosis of the vertebra or abdominal vascular calcification. The correlation between the SPA and the DXA was favorable in determining BMD at the distal one-third of the radius. The correlation between Jensen's classification based on subperiosteal resorption, intact-PTH, and BMD(radius) was favorable. The annual decrease in BMD was 4.0% and 4.7% in the male patients within 8 years and the female within 6 years after starting dialysis, respectively, and thier BMD decreased to 70 at above mentioned year. The annual BMD decrease became larger in the patients with severe 2'HPT, i.e., 7.1% in the male patients and 10.0% in the female patients. BMD after PTX markedly increased in the patients showing BMD of less than 70 at PTX. The BMD in one male patient who showed aluminium induced osteomalacia in past history was maintained at a relatively favorable value. The biochemical examination of two female patients who became an aparathyroid state after PTX showed improved values, but their BMD gradually decreased without showing any increase.     

Heel ultrasound in women after long-term ERT compared with bone densities in the forearm,spine and hip

To compare heel ultrasound values with bone densitites at different measurement sites as determined by single photon absorptiometry (SPA) and dual-energy X-ray absorptiometry (DXA) in long-term users of estrogen replacement therapy (ERT), we analyzed data from 30 users of estradiol implants (mean duration of treatment 16 years) and 32 non-users, comprising 28 complete age-matched pairs. The precision errors in vivo of ultrasound measurements were 0.18%, 1.3% and 1.5% for speed of sound (SOS), broadband ultrasound attenuation (BUA) and stiffness index, respectively. In the controls, ultrasound parameters correlated well with values from SPA and DXA measurements (r=0.51–0.63,p<0.004). In long-term users of ERT, however, measurements with ultrasound did not correlate with DXA in the spine and hip (r=0.01–0.31, NS) but correlated well with SPA in the forearm (r=0.47–0.66,p<0.009). Implant users, compared with non-users, had small and just significantly different values when measured by ultrasound (at most 12%,p=0.03–0.04) but significantly higher bone mineral densities (18%–25%,p=0.0001–0.01) in the forearm, spine and hip when measured by SPA or DXA. Data indicated that a substantial proportion of long-term users of estrogen may be non-responders concerning the effect of estrogen on bone qualities expressed in heel ultrasound values. In a multivariate regression analysis the effect of increasing age and increasing treatment duration were both negative for the ultrasound parameters. This is in contrast to our previous finding for bone density parameters in which the negative effect of increasing age was more than compensated by the positive effect of increasing treatment duration. Heel ultrasound correlated poorly with DXA measurement of axial bone density in long-term estrogen users. It has been stated that ultrasound measurements of bone status represent architecture and structure independently of bone mass. If so, then longterm ERT seems, in a substantial proportion of women, to preserve the bone mass and density better than the structure of the bone. Thus, the present study demonstrates a situation where ultrasound determinations can not simply be extrapolated to reflect the mineral density of the central skeleton.     

Bone mineral density and bone turnover markers in children with chronic renal failure

Bone mineral density (BMD) at lumbar spine (L₂-L₄) was measured by dual-energy X-ray absorptiometry (DEXA) in 21 children with predialysis chronic renal failure (CRF) and 44 children with end-stage renal failure (ESRF) on regular hemodialysis. BMD results were expressed as Z-scores. Osteopenia was documented in 13 predialysis patients (61.9%) and 26 patients (59.1%) with ESRF. No significant correlation was observed between Z-scores and the duration of CRF or estimated creatinine clearance. In osteopenic children there was a negative correlation between Z-scores and serum phosphorus (r=–0.61, P=0.004), intact parathyroid hormone (iPTH) (r=–0.47, P=0.03), and bone-specific alkaline phosphatase (r=–0.52, P=0.02) and a positive correlation with total calcium (r=0.41, P=0.07) and 25-hydroxycholecalciferol (r=0.53, P=0.02). Osteopenic children who had iPTH values 200 pg/ml were more osteopenic than those who had lower iPTH levels (P=0.006). In conclusion, osteopenia, assessed by DEXA, is frequent in children with CRF. It occurs early irrespective of the duration or the severity of CRF. In children with ESRF the degree of osteopenia is correlated with laboratory markers of renal osteodystrophy and patients with biochemical findings of secondary hyperparathyroidism are more osteopenic than the others.     

Bone mineral density measurement in puerperal women as a predictor of persistent osteopenia

The clinical value of bone mineral density (BMD) measurement in puerperal women is uncertain. Our aim was to examine the effectiveness of BMD measurement in puerperal women for identification of persistent osteopenia and osteoporosis. We addressed cross-sectional and longitudinal changes in BMD, assessed using dual-energy X-ray absorptiometry (DXA), in a postpartum female cohort from a single center in Japan. We measured BMD of the lumbar spine (L2–L4) with DXA in 2,436 puerperal women within 7 days of delivery (study 1). For 210 of the women, the BMD was measured again after 5–10 years (study 2). In study 1, 8 (0.3%) of the women were osteoporotic, 37 (17.0%) were osteopenic, and 2,013 (82.6%) were normal. In study 2, 27 (71.1%) of the 38 osteoporotic or osteopenic women identified in the puerperal scan were still osteopenic at the scan after 5–10 years. Over the same period, only 7 (4.1%) of 172 initially normal women became osteopenic. The mean of the BMD change per year was 0.15 ± 0.82%/year. Osteopenia was associated with a significantly lower body weight and body mass index at puerperium and after 5–10 years compared to normal women. The multiple regression analysis showed that BMD at the first scan negatively contributed and body weight changes between the scans positively significantly contributed to the BMD changes per year. Puerperal BMD remained static over the subsequent 5–10 years. If the women have a low BMD at this stage of their reproductive life, it tends not to improve over this time. Perhaps identification of this at-risk group may lead to effective interventions to reduce fracture risk in later life.     

Dxa longitudinal quality control: a comparison of inbuilt quality assurance, visual inspection, multi-rule shewhart charts and cusum analysis

The performance of dual-energy X-ray absorptiometry (DXA) instruments can be monitored using various quality control (QC) procedures. It has not been established which of these is most appropriate. The aim of this study was to determine which of four QC procedures is the best to use for longitudinal monitoring. Eighteen centres with DXA instruments scanned an aluminium spine phantom weekly for up to 16 months, and the bone mineral density data were used for the QC procedures. The methods investigated were the instrument's inbuilt quality assurance (QA) procedure, visual inspection, multi-rule Shewhart control charts, and Cusum analysis using a truncated-V mask. True and false positive fractions (TPF and FPF) of each method were calculated, including those for a range of action levels for the Shewhart charts and dimensions of the Cusum mask. For Shewhart, the action levels giving the most desirable TPF and FPF were whole multiples of the standard deviation (SD). For Cusum, the most desirable mask dimensions were 3.6 SD for the total height of the vertical section and 0.9 SD per data point for the gradient of the wings. Predictive power of each method as a means of fault detection was decided by the number of faults detected out of a total of 8 non-mechanical faults subsequently diagnosed. The inbuilt QA detected 2, visual inspection 7, Shewhart chart 7 and Cusum analysis 7. The FPFs were: visual inspection 0.09, Shewhart 0.04, Cusum 0.08. At these levels of FPF, the average time in days (range) from onset of a fault to detection was 39 (6–82) for visual inspection, 39 (4–116) for Shewhart and 21 (1–49) for Cusum. All three phantom methods are excellent for DXA QC, with modified Cusum analysis being the most effective. The inbuilt QA appears of little use on its own for longitudinal QC.     

Comparison of areal and estimated volumetric bone mineral density values between older men and women

We compared areal bone mineral density (BMD) of the total body (TBMD), antero-posterior lumbar spine at L3 (APS), lateral spine at L3 (LS) and femoral neck (FN). In order to understand better the effect of gender-related size differences on BMD, we also compared the estimated volumetric BMD at L3 (VLS) and the femoral neck (VFN). Subjects were asymptomatic women (n=22) and men (n=44) with an age range of 58–79 years. BMD at each site was measured by dual-energy X-ray absorptiometry using a Hologic 2000 in array mode. Results of the statistical analyses (ANOVA) showed the men to have significantly greater BMD at all areal sites [APS, LS (p<0.05); FN (p<0.01); TBMD (p<0.001)]. The two estimated volumetric comparisons, however, showed no gender differences. Results demonstrate how measures from areal BMD measures can be misleading when comparing groups of different size. In older men and women planar measures may overestimate gender differences in BMD.     

Vertebral bone mineral density measured laterally by dual-energy X-ray absorptiometry

The bone mineral density (BMD) of lumbar vertebrae in the anteroposterior (AP) view may be overestimated in osteoarthritis or with aortic calcification, which are common in elderly. Furthermore, the risk of spinal crush fracture should be more closely related inversely to the BMD of the vertebral body than to that of the posterior arch. Therefore, we measured BMD of lumbar vertebrae in lateral (LAT) view (L2–L3), using a standard dual-energy X-ray absorptiometer (DEXA), thus eliminating most of the posterior spinal elements. The precision of BMD LAT measurement was determined both in vitro and in healthy volunteers. Then, we compared the capability of BMD LAT and BMD AP scans for monitoring bone loss related to age and for discriminating the BMD of postmenopausal women with nontraumatic vertebral fractures from that of young subjects. In vitro, when a spine phantom was placed in lateral position in the middle of 26 cm of water in order to simulate both soft-tissue thickness and X-ray source remoteness, the coefficient of variation (CV) of six repeated determinations of BMD was 1.0%. In vivo, the CV of paired BMD LAT measurements obtained in 20 healthy volunteers after repositioning was 2.8%. The age-related difference between a peak bone mass group estimated in a group of 27 healthy women aged 20 to 35 years and a group of 50 women aged 60 to 75 years, in whom neither vertebral fracture nor osteoporosis risk factors could be detected, were 21.7% and 37.6% in AP and LAT view, respectively. An arbitrary BMD fracture threshold was defined in AP and LAT views as the 90th percentile of the BMD value of a group of 22 osteoporotic women with vertebral fractures. The distribution of BMD AP and LAT above and below this threshold in 169 consecutively screened women without vertebral fracture was then analysed. In both AP and LAT views, 39.1% and 31.3% had BMD values above and below this threshold, respectively. Of the remaining, 16.0% had a BMD below this threshold only in AP and 13.6% only in LAT view. Thus, if BMD LAT was a better reflection of vertebral body bone mass than BMD AP, and thereby a better predictor of the resistance to crush fracture, our results would suggest that only the use of the standard AP view could under- or overestimate spinal fracture risk in about 30% of women screened for osteoporosis. In conclusion, our results indicate that BMD measurement in lateral view is feasible with a standard DEXA instrument. This mode of scanning, besides overcoming artefacts due to osteoarthritis of the posterior arch and aortic calcifications, appears to provide a greater sensitivity for assessing bone mass loss of the vertebral body than the standard anteroposterior scan.     

Bone mineral density and bone histomorphometry in children on long-term dialysis

Bone mineral density (BMD) at the lumbar vertebrae (L(1)-L(4)) was assessed by dual-energy X-ray absorptiometry (DXA) in 20 children with chronic kidney disease (CKD) on dialysis, and its results were compared with bone biopsy and biochemical parameters. Biopsy specimens provided evidence of hyperparathyroid bone disease in eight cases (40%), and low bone turnover in 12 (60%). For BMD, expressed as Z-scores relative to normal, median Z-scores were -1.05 (range -2.36 to 1.06) for hyperparathyroid patients and -1.05 (range -4.40 to -0.03) for low bone turnover patients, with no statistical differences between groups (P = 0.512). In relation to BMD, of the whole sample, five (25%) had a Z-score under -2.0. When it was corrected for height, BMD was in the normal range. Additionally, there were no significant differences in single samples of serum calcium, alkaline phosphatase, phosphorus and intact parathyroid hormone (PTH) between groups with high or low bone turnover. Assessment of nutritional status, through height/age, showed that ten patients had Z-scores below -2.0 (median -2.12, range -7.13 to 0.73). In conclusion, renal osteodystrophy (ROD) seems to have a high prevalence among CKD pediatric patients, although only approximately a quarter of them developed changes in BMD. In children with CKD, measurements of bone mineral density may not be used for classification of various forms of ROD.     

股骨近端骨密度的测量

双能X线骨密度仪检测骨密度是诊断骨质疏松症和疗效随访的金标准,特别是髋部骨密度的测量对于骨折的预测尤其测定部位本身骨折的预测作用较大.由于脊柱部位的骨密度测量值易受到脊柱退行性疾病的病理改变如退行性侧凸、骨赘增生、腰椎间盘突出等影响,测量的准确性下降.因而近年来欧美国家临床试验也好或者骨质疏松诊疗也好,大都以股骨近端的BMD测定为标准.本文就股骨近端解剖特点、骨密度测量的意义、方法以及测量的注意点作一个综述,以期帮助临床医生或技术员全面评估股骨近端骨密度测定的意义.     

体重体成分与骨密度的关系

为了研究体成分与骨密度（ＢＭＤ）之间的关系，因体重与ＢＭＤ显著相关，体成分各个组成相加等于体重，而体成分与ＢＭＤ的关系仍不清楚。方法随机选取２０６名１６～５２岁健康的男女性汉族人，用双能Ｘ射线吸收法（ＤＸＡ）测量ＢＭＤ与体成分，进行ＢＭＤ与体重，体成分的多元线性回归分析。结果体重，瘦组织（ＬＴＭ）与男女性的ＢＭＤ显著正相关，脂肪组织（ＦＴＭ）仅对女性全身，腰椎ＢＭＤ起显著性作用。结论影响男女性ＢＭＤ的体成分中，ＬＴＭ是主要因素，ＦＴＭ仅对女性ＢＭＤ有影响。本文较全面地研究了体成分与ＢＭＤ的关系。     

Artifactual Reduction in Bone Density as a Result of Technetium MDP for Bone Scanning: Report of Two Cases

We present two patients in whom marked changes in dual-energy X-ray absorptiometry (DXA)-measured bone mineral density were found to be the result of prior administration of technetium-99m methylene diphosphonate (MDP) for bone scanning. In patient 1, an artifactual 50% decrease in lumbar spine and 19% decrease in left total hip bone density over a 14-mo period was the result of technetium-99m injection 3 h before the second bone density measurement. In patient 2, a dramatic increase in bone density at 6 mo was the result of artifactual reduction in bone density on the baseline study as a result of technetium-99m injection 2 h earlier. Clinicians and technologists should be aware that technetium-99m used for bone scanning could cause artifactual reduction in DXA-measured bone mineral density.     

Bone mineral density after total joint arthroplasty of lower extremities in rheumatoid arthritis patients

We studied the effects on the axial bone mass of total joint arthroplasty (TJA) for lower extremities in 48 female rheumatoid arthritis (RA) patients by using dual-energy X-ray absorptiometry (DXA). Twenty-nine postmenopausal RA patients treated only with nonsteroidal anti-inflammatory drugs (NSAIDs) served as controls. They were studied for an average duration of 63 months. The reduction in the bone mineral density (BMD) of the lumbar spine (L2–4) was significant in both groups (p < 0.01∼0.05), but it was not statistically different between the two groups. The BMD of the femoral neck decreased significantly in both groups (p < 0.01–0.05) after 2 years, but it was not statistically different between the two groups. Our data suggest that TJA slowed the rapid axial bone loss usually associated with advanced RA. Received: 7 February 2000     

Evaluation of the European spine phantom in a multi-centre clinical trial

The European Spine Phantom (ESP) has recently been developed as a universal standard for instruments measuring bone density. The ESP is composed of three semi-anthropomorphic hydroxyapatite vertebrae of varying densities surrounded by soft tissue equivalent plastic designed to resemble human bone and soft tissue when scanned on bone densitometers. In multi-centre studies it is particularly important to verify that each participating bone densitometer is performing in a stable and linear fashion. The aim of this study was to evaluate the ESP within the context of a multi-centre clinical trial. Eighteen centres in the UK and Canada with dual-energy X-ray absorptiometry (DXA) instruments (Lunar DPX, DPX-alpha and DPX-L) participated in the study. The ESP was scanned 10 times on each instrument without repositioning using standardized protocols. The precision of the bone mineral density (BMD) measurements (L1–3) expressed as a coefficient of variation ranged from 0.4% to 1.1% (mean 0.7%). The mean BMD of each instrument was expressed as a percentage difference from the overall mean and ranged from −1.33% to 1.33%. Linear regression analysis showed that all instruments behaved in a linear fashion across the range of densities with correlation coefficients all ≥0.999 and standard errors of the estimate <1.5% of the mean BMD ESP value. The data from this study demonstrate that the ESP is a useful phantom for assessing the linearity, stability and differences between DXA instruments from one manufacturer.     

双能X线吸收法腰椎侧位骨密度测定的临床研究

目的评价双能X线吸收法测定腰椎骨密度时侧位的临床价值。方法178例女性患者(按年龄分组)接受腰椎后前位和侧位骨密度测定,以BMD表示骨密度值,以T值为标准判断骨量正常、骨量减少和骨质疏松,评价腰椎后前位与侧位T值对骨量减少程度的判断和骨质疏松诊断的差别。结果①各年龄组患者腰椎后前位BMD值均高于侧位值;②各年龄组患者腰椎后前位及侧位T值对骨量减少程度的判断有显著性差别;③当大于50岁时,腰椎后前位及侧位T值对骨质疏松诊断有显著性差别。结论腰椎侧位对女性患者骨量减少程度的判断和骨质疏松的诊断(>50岁)都有一定临床价值。     

Dual-energy X-ray absorptiometry in normal women: A cross-sectional study of 717 finnish volunteers

The bone mineral density (BMD) of the lumbar spine and proximal femur was measured using dual-energy X-ray absorptiometry in 717 healthy women aged 20–70 years. The maximal mean BMD was found at the age of 35–39 years in the spine and at the age of 20–24 in the femoral neck and Ward's triangle. No significant change in lumbar BMD was found from the age of 20 to 39 years. The spinal BMD values were relatively stable from age 20 to 39 years, whereas a linear decrease in BMD in the femoral neck and Ward's triangle was already apparent in the youngest age group (20–24 years). The major fall in BMD in all sites was related to the menopause. The overall decreases in BMD from the peak values to those at age 65–70 years were 20.4%, 19.0% and 32.6% in the lumbar spine, femoral neck and Ward's triangle, respectively. The correlation of trochanteric BMD with age was poor. BMD was positively correlated with weight in all measurement sites. Nulliparity was found to be a risk factor for osteoporosis. The present study confirmed that the menopause has a significant effect not only on spinal BMD but also on femoral BMD. Lumbar BMD was lower and BMDs in the proximal femur were higher in Finnish women than in white American women. This emphasizes the importance of national reference values for BMD measurements.     

Bone mineral density and turnover in patients with acromegaly in relation to sex, disease activity, and gonadal function

Acromegaly is a rare disease caused by growth hormone (GH) hypersecretion. GH and insulin-like growth factor-I (IGF-I) exert anabolic activity in bones. Nevertheless, bone mineral density (BMD) loss is not uncommon in patients with acromegaly. It is assumed to be due to hypogonadism associated with the acromegaly. The aim of the study was to examine BMD at various skeletal sites and bone turnover and to assess the influence of impaired gonadal function and disease activity on BMD and turnover changes in acromegaly. A total of 62 patients were studied (40 women, 22 men). Among the women, 22 had active disease and 18 were cured; 16 women had normal gonadal function, and 24 were hypogonadal. Altogether, 12 men presented with active acromegaly, and 10 were cured; normal gonadal function was found in 10 men, and hypogonadism was diagnosed in 12 men. Controls were 30 healthy subjects. Densitometry using dual-energy X-ray absorptiometry of the lumbar spine, proximal femur, forearm, and total body was carried out. Bone turnover was studied based on serum osteocalcin, C-terminal collagen type 1 crosslinks, and bone alkaline phosphatase concentration. A disadvantageous effect of acromegaly on bone density was associated with hypogonadism in the distal radius (in women), the proximal femur (in men), and the total body (both sexes). An anabolic effect of GH during active acromegaly was present in the proximal femur only in men. We confirmed increased bone turnover in the presence of acromegaly, and these changes were similar regarding the activity of the disease and the gonadal status.     

Early postmenopausal diminution of forearm and spinal bone mineral density: A cross-sectional study

Diminution of bone mineral density (BMD) in the spine and forearm was studied cross-sectionally in 363 women who were 6 months to 10 years postmenopausal. BMD was determined by dual-energy X-ray absorptiometry (DXA) (Hologic QDR-2000) in the lumbar spine, in both the supine lateral (LAT) and anteroposterior (AP) projections, and in the distal third of the forearm. The postmenopausal diminution of BMD was best described by an exponential fit. The initial rate of postmenopausal diminution of BMD was highest in the most trabecular sites (LAT>AP> forearm), but 10-year diminution was similar at all sites (12%–13%, corresponding to about 1.0–1.5 SD), and extrapolation suggested reverse order of the rates of diminution thereafter (forearm>AP>LAT). When bone mineral content of the entire L3 vertebra (tBMC) was measured in vivo, AP tBMC could account for only 67% of the variation in LAT tBMC, compared withr ²=0.997 in vitro. This observation suggests an accuracy problem in vivo in one of the spine measurement methods. We conclude that the initial rate of BMD diminution after the menopause seems to be highest in the spine, especially when measured laterally, but that this rate levels off within the first decade. The lower precision error of a forearm measurement (0.8% v 1.6 for AP and 3.1 for LAT) therefore implies that this method may require a shorter observation period than spine measurements for the detection of bone loss 5–10 years after menopause. Long-term longitudinal spine and forearm measurements are, however, needed to confirm these conclusions.